Delivery Systems, Ingredient Labels, Irritation, and Allergy

Formulation efficacy and cutaneous safety depend directly on delivery kinetics and biocompatibility. To optimize clinical results and prevent adverse complications, master estheticians must master transdermal penetration pathways, transport constraints, advanced encapsulation systems, comedogenicity standards, and the diagnostic distinction between Irritant Contact Dermatitis (ICD) and Allergic Contact Dermatitis (ACD).

Transdermal Permeation Pathways & the Stratum Corneum Barrier

The stratum corneum operates under Elias's "brick and mortar" model: anucleated, keratin-dense corneocytes ("bricks") surrounded by an extracellular lamellar lipid matrix ("mortar") containing ceramides, cholesterol, and free fatty acids in variable proportions.

Topical actives traverse this barrier through three distinct routes:

1. Intercellular Pathway (The Primary Route): Actives diffuse through the continuous, tortuous extracellular lipid lamellae surrounding corneocytes. Because the lipid matrix forms an uninterrupted phase across the stratum corneum, its contribution depends on the molecule and formulation.
2. Transcellular Pathway: Actives pass directly through corneocytes and intercellular lipids sequentially. Molecules must alternately cross hydrophilic protein envelopes and hydrophobic lipid layers, requiring balanced amphiphilic solubility.
3. Transappendageal Pathway (The Shunt Route): Some substances can use appendage-associated routes through hair follicles, sebaceous ducts, and eccrine sweat pores. Although appendages occupy only 0.1% to 1.0% of total skin surface area, this route serves as a rapid shunt for ions, large polar molecules, and follicularly targeted lipophilic agents (e.g., salicylic acid).

Molecular properties and penetration

Molecular mass, solubility, charge, vehicle, concentration, skin condition, and route affect topical penetration. The often-cited 500-Dalton rule is a useful heuristic for passive penetration through intact skin, not an absolute border that every smaller molecule crosses and every larger molecule can never cross.

A delivery system can alter release or localization, but its name does not prove clinical penetration depth. Intentionally damaging the barrier to increase delivery changes the risks and may involve medical authority. Do not use needling or abrasion to make an unapproved serum reach a deeper target.

Encapsulation and release

Liposomes are vesicular structures with lipid bilayers. Other encapsulation systems include particles or porous carriers with different materials and release properties. Nanosome is not one universally defined polymeric architecture. Microsponges do not all release for an identical eight-to-twelve-hour period.

A formulation may use encapsulation for stability, release control, or localization. The actual evidence and intended use matter. A package word such as nano does not mean the ingredient reaches dermal fibroblasts, is more effective, or is safe for every post-procedure application.

Chemical Penetration Enhancers

Penetration enhancers reversibly diminish barrier resistance:

• Alcohols (Ethanol): Extract intercellular lipids, fluidizing bilayer lamellae.
• Glycols (Propylene Glycol): Solvate keratin and improve active thermodynamic partitioning.
• Terpenes (Menthol, Limonene): Disrupt lipid hydrocarbon packing to enhance membrane fluidity.

Comedogenicity and whole formulations

Ingredient ratings from historical tests cannot reliably predict every finished product's effect on every person. Test model, concentration, vehicle, and use differ. Do not label all coconut oil, mineral oil, or surfactants as universally pore-clogging from a numerical table.

Assess the complete product and the client's actual response. New breakouts can have several causes and may coincide with medicine, hormones, friction, or another product. Record chronology and avoid diagnosing causation from one ingredient list. Irritation and comedone formation are also different processes.

Irritation and allergy

Irritant contact dermatitis can result from direct injury or repeated exposure. Allergic contact dermatitis involves an immune response in a sensitized person. Timing, distribution, and symptoms can overlap; irritation is not always immediate, and a delayed rash does not prove allergy without medical assessment.

Stop unsuitable exposure, document the product and chronology, and refer significant or recurrent reactions. Do not perform a diagnostic patch test independently or declare a product hypoallergenic because a small area looked normal once.

Labels and safe testing instructions

Fragrances, preservatives, botanicals, and many other ingredients can be relevant to a reaction. Follow any product-specific compatibility testing directions, recognizing that a negative small-area result does not guarantee safety across a larger region. Medical patch testing and repeat open application testing are structured diagnostic processes; one application observed at twenty-four, forty-eight, and seventy-two hours is not automatically a repeat-open-application test.

Retail cosmetic ingredient declarations generally list ingredients in descending order of predominance, with specified exceptions. Ingredients at one percent or less may follow the higher-concentration ingredients in any order, and color additives have separate provisions. The list does not disclose every exact percentage. A product that is also a drug has additional active-ingredient and labeling requirements.

Do not infer the percentage of an active solely from its position near fragrance, or assume professional labeling removes all retail obligations when a product is sold to consumers. Virginia also requires accurate product labeling and closed storage in the spa. Decanted containers need clear identification and hygienic handling.

A client with a known fragrance allergy asks for a botanical serum. Review the actual formulation and avoid the known allergen. Natural does not mean fragrance-free. If the exact ingredients or intended use cannot be established, do not guess from the plant image on the box. Ingredient literacy supports selection, but cannot replace client assessment and the actual instructions.

Sources and current rules

FDA cosmetic labeling guide. Checked October 7, 2026.